News & Updates

SingHypertension: Primary care intervention for BP control deemed cost-effective

26 Apr 2024 by

A multicomponent intervention to control elevated blood pressure (BP) levels at the primary care level, SingHypertension, represents good value for money for reducing hypertension-related morbidity and mortality in Singapore, according to a cost-effectiveness study.

SingHypertension: Primary care intervention for BP control deemed cost-effective

26 Apr 2024

Intranasal oxytocin may reduce irritability in youths with mood disorders

26 Apr 2024

Treatment with intranasal oxytocin appears to produce neural-level changes in emotion processing among young people with irritability caused by disruptive behaviour disorders (DBDs) or disruptive mood dysregulation disorder (DMDD), suggests a study.

Intranasal oxytocin may reduce irritability in youths with mood disorders

26 Apr 2024

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

26 Apr 2024 by

Use of transcatheter aortic valve implantation (TAVI) does not increase the risks and contributes to a decrease in the rates of death or stroke at 1 year in patients with severe aortic stenosis when compared with surgical aortic-valve replacement (SAVR), suggests a study presented at ACC.24.

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

26 Apr 2024

Baseline eGFR predicts inhibitor-induced AKI

26 Apr 2024

A recent study has found three baseline characteristics that can predict sustained acute kidney injury (AKI), and these include estimated glomerular filtration rate (eGFR), loop diuretic, and spironolactone use. For immune checkpoint inhibitor-related AKI, only baseline eGFR is predictive.

Baseline eGFR predicts inhibitor-induced AKI

26 Apr 2024

Vertical COVID-19 transmission low in SG

26 Apr 2024 by

Transmission of SARS-CoV-2 infection from mothers to newborns appears to be rare in a cohort study conducted by the KK Women’s and Children’s Hospital (KKH), Singapore General Hospital (SGH), and National University Hospital (NUH).

Vertical COVID-19 transmission low in SG

26 Apr 2024

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

New drug applications approved by US FDA as of 1-15 April 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

Electrical stimulation alleviates anxiety in patients undergoing laparoscopic resection

26 Apr 2024

For patients undergoing laparoscopic resection for colorectal cancer (CRC), two sessions of transcranial direct current stimulation (tDCS) help reduce perioperative anxiety, as reported in a study.

Electrical stimulation alleviates anxiety in patients undergoing laparoscopic resection

26 Apr 2024

Intranasal zavegepant offers freedom from pain in women with acute migraine

26 Apr 2024 by

The use of nasal spray zavegepant 10 mg provides freedom from pain and the most bothersome migraine symptom (MBS*) at 2 hours after treatment in women with acute migraine, according to the pooled analysis of the two trials presented at AAN 2024.

Intranasal zavegepant offers freedom from pain in women with acute migraine

26 Apr 2024

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

25 Apr 2024 by

Using intravascular ultrasound (IVUS) to guide stent placement in patients with acute coronary syndrome (ACS) appears to reduce the 1-year risk of target vessel failure as compared with using angiography alone, according to the results of the IVUS-ACS study.

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

25 Apr 2024

Pharmacist-driven program viable in patients taking antineoplastic agents

25 Apr 2024

A pharmacist monitoring program is feasible and useful for patients receiving oral antineoplastic agents, reports a recent study.

Pharmacist-driven program viable in patients taking antineoplastic agents

25 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

SingHypertension: Primary care intervention for BP control deemed cost-effective

SingHypertension: Primary care intervention for BP control deemed cost-effective

Intranasal oxytocin may reduce irritability in youths with mood disorders

Intranasal oxytocin may reduce irritability in youths with mood disorders

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

Baseline eGFR predicts inhibitor-induced AKI

Baseline eGFR predicts inhibitor-induced AKI

Vertical COVID-19 transmission low in SG

Vertical COVID-19 transmission low in SG

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Electrical stimulation alleviates anxiety in patients undergoing laparoscopic resection

Electrical stimulation alleviates anxiety in patients undergoing laparoscopic resection

Intranasal zavegepant offers freedom from pain in women with acute migraine

Intranasal zavegepant offers freedom from pain in women with acute migraine

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

Pharmacist-driven program viable in patients taking antineoplastic agents

Pharmacist-driven program viable in patients taking antineoplastic agents